Document:

exhibit10-19.htm

    AGREEMENT

    

    CONCERNING
THE EXCHANGE OF SECURITIES

    

    BY
AND AMONG

    

    GEOBIO
ENERGY, INC.

    

    AND

    

    ENVIROPLASTICS
CORPORATION AND

    

    THE
SECURITY HOLDERS OF ENVIROPLASTICS CORPORATION

    INDEX

    
      

      
        	
                ARTICLE
      I – Exchange of Securities

              	 
      2
	 
      	 
      
	
                1.1

              	
                Issuance
      of Securities

              	 
      2
	
                1.2

              	
                Exemption
      from Registration

              	 
      2
	 
      	 
      	 
      
	
                ARTICLE
      II – Representations and Warranties of EnviroPlastics
      Corporation

              	 
      2
	 
      	 
      
	
                2.1

              	
                Organization

              	 
      2
	
                2.2

              	
                Capital

              	 
      2
	
                2.3

              	
                Subsidiaries

              	 
      2
	
                2.4

              	
                Directors
      and Executive Officers

              	 
      2
	
                2.5

              	
                Financial
      Statements

              	 
      2
	
                2.6

              	
                Absence
      of Changes

              	 
      3
	
                2.7

              	
                Absence
      of Undisclosed Liabilities

              	 
      3
	
                2.8

              	
                Tax
      Returns

              	 
      3
	
                2.9

              	
                Investigation
      of Financial Condition

              	 
      3
	
                2.10

              	
                Intellectual
      Property Rights

              	 
      3
	
                2.11

              	
                Compliance
      with Laws

              	 
      3
	
                2.12

              	
                Litigation

              	 
      3
	
                2.13

              	
                Authority

              	 
      3
	
                2.14

              	
                Ability
      to Carry Out Obligations

              	 
      3
	
                2.15

              	
                Full
      Disclosure

              	 
      3
	
                2.16

              	
                Assets

              	 
      3
	
                2.17

              	
                Material
      Contracts

              	 
      3
	
                2.18

              	
                Indemnification

              	 
      3
	
                2.19

              	
                Criminal
      or Civil Acts

              	 
      3
	
                2.20

              	
                Restricted Securities

              	 
      3
	 
      	 
      	 
      
	
                ARTICLE
      III – Representations and Warranties of GeoBio Energy,
Inc.

              	 
      4
	 	 	 
	
                3.1

              	
                Organization

              	 
      4
	
                3.2

              	
                Capital

              	 
      4
	
                3.3

              	
                Subsidiaries

              	 
      4
	
                3.4

              	
                Directors
      and Executive Officers

              	 
      4
	
                3.5

              	
                Financial
      Statements

              	 
      4
	
                3.6

              	
                Financing

              	 
      4
	
                3.7

              	
                Absence
      of Changes

              	 
      4
	
                3.8

              	
                Absence
      of Undisclosed Liabilities

              	 
      4
	
                3.9

              	
                Tax
      Returns

              	 
      4
	
                3.10

              	
                Investigation
      of Financial Condition

              	 
      4
	
                3.11

              	
                Intellectual
      Property Rights

              	 
      4
	
                3.12

              	
                Compliance
      with Laws

              	 
      4
	
                3.13

              	
                Litigation

              	 
      4
	
                3.14

              	
                Authority

              	 
      4
	
                3.15

              	
                Ability
      to Carry Out Obligations

              	 
      5
	
                3.16

              	
                Full
      Disclosure

              	 
      5
	
                3.17

              	
                Assets

              	 
      5
	
                3.18

              	
                Material
      Contracts

              	 
      5
	
                3.19

              	
                Indemnification

              	 
      5
	
                3.20

              	
                Criminal
      or Civil Acts

              	 
      5
	 
      	 
      	 
      
	
                ARTICLE
      IV – Covenants Prior to the Closing Date

              	 
      5
	 
      	 
      
	
                4.1

              	
                Investigative
      Rights

              	 
      5
	
                4.2

              	
                Conduct
      of Business

              	 
      5
	
                4.3

              	
                Confidential
      Information

              	 
      5
	
                4.4

              	
                Notice
      of Non-Compliance

              	 
      5
	 
      	 
      	 
      
	
                ARTICLE
      V – Conditions Precedent to GeoBio Energy, Inc.’
    Performance

              	 
      5
	 
      	 
      	 
      
	
                5.1

              	
                Conditions

              	 
      5
	
                5.2

              	
                Accuracy
      of Representations

              	 
      6
	
                5.3

              	
                Performance

              	 
      6
	
                5.4

              	
                Absence
      of Litigation

              	 
      6
	
                5.5

              	
                Officer’s
      Certificate

              	 
      6
	
                5.6

              	
                Corporate
      Action

              	 
      6
	
                5.7

              	
                Acceptance
      of Financial Statements

              	 
      6
	 
      	 
      	 
      
	
                ARTICLE
      VI – Conditions Precedent to EnviroPlastics Corporation’s
      Performance

              	 
      6
	 
      	 
      	 
      
	
                6.1

              	
                Conditions

              	 
      6
	
                6.2

              	
                Accuracy
      of Representations

              	 
      6
	
                6.3

              	
                Performance

              	 
      6
	
                6.4

              	
                Absence
      of Litigation

              	 
      6
	
                6.5

              	
                Officer’s
      Certificate

              	 
      6
	
                6.6

              	
                Payment
      of Liabilities

              	 
      6
	
                6.7

              	
                Directors
      of GeoBio

              	 
      6
	
                6.8

              	
                Officers
      of GeoBio

              	 
      6
	 
      	 
      	 
      
	
                ARTICLE
      VII – Closing

              	 
      6
	 
      	 
      	 
      
	
                7.1

              	
                Closing

              	 
      6
	 
      	 
      	 
      
	
                ARTICLE
      VIII – Covenants Subsequent to the Closing Date

              	 
      7
	 
      	 
      	 
      
	
                8.1

              	
                Registration
      and Listing

              	 
      7
	 
      	 
      	 
      
	
                ARTICLE
      IX – Miscellaneous

              	 
      7
	 
      	 
      	 
      
	
                9.1

              	
                Captions
      and Headings

              	 
      7
	
                9.2

              	
                No
      Oral Change

              	 
      7
	
                9.3

              	
                Non-Waiver

              	 
      7
	
                9.4

              	
                Time
      of Essence

              	 
      7
	
                9.5

              	
                Entire
      Agreement

              	 
      7
	
                9.6

              	
                Choice
      of Law

              	 
      7
	
                9.7

              	
                Counterparts

              	 
      7
	
                9.8

              	
                Notices

              	 
      7
	
                9.9

              	
                Binding
      Effect

              	 
      7
	
                9.10

              	
                Mutual
      Cooperation

              	 
      7
	
                9.11

              	
                Finders

              	 
      7
	
                9.12

              	
                Announcements

              	 
      8
	
                9.13

              	
                Expenses

              	 
      8
	
                9.14

              	
                Survival
      of Representations and Warranties

              	 
      8
	
                9.15

              	
                Exhibits

              	 
      8
	
                9.16

              	
                Unwinding, Termination,
      Amendment and Waiver

              	 
      8
	 
      	 
      	 
      
	 
      	
                Exhibits

              	 
      
	 
      	 
      	 
      
	
                1.1

              	
                EP
      Security Holders

              	 
      
	
                1.2

              	
                EP
      Subscription Agreements

              	 
      
	
                2.5

              	
                Financial
      Statements for EP(if available)

              	 
      
	
                2.7

              	
                EP
      Liability Schedule

              	 
      
	
                2.8

              	
                Provisions
      for taxes (if any)

              	 
      
	
                2.16

              	
                Assets
      of EP

              	 
      
	
                2.17

              	
                Material
      Contractsof EP

              	 
      
	
                3.5

              	
                Financial
      Statements for GeoBio

              	 
      
	
                3.8

              	
                GeoBio provisions for
      Tax Returns(if
      any)

              	 
      
	
                3.17

              	
                Material
      Contracts for GeoBio

              	 
      
	 
      	 
      	 
      

      

      
        
           

        

        
          1

          
            

          

        

        
           

        

      

    

    

    MERGER
BY SHARE EXCHANGE

    AGREEMENT

    

    THIS AGREEMENT (“Agreement”)
is made this ___  day of March 2009, by and between GeoBio Energy,
Inc. a Colorado corporation (“GeoBio”),
EnviroPlastics Corporation, a Nevada corporation (“EP”)
and the security holders of EP (the “EP
Security Holders”) who are listed on Exhibit 1.1
hereto.

    

    WHEREAS, GeoBio desires to acquire all
of the issued and outstanding common stock of EP (“EP
Stock”) from the EP Security Holders in exchange for common stock of
GeoBio; and

    

    WHEREAS, all of the EP Security Holders
agree to exchange one hundred percent (100%) of the EP Stock they hold in EP for
such share
amount which equals ninety percent (90%) of the issued and outstanding shares of
GeoBio common stock  at the time of the Closing (defined below) of
this Agreement (the “Shares”).

    

    NOW, THEREFORE, in consideration of the
mutual promises, covenants and representations contained herein, the parties
hereto agree as follows:

    

    ARTICLE
I

    Exchange
of Securities

    

    1.1           Issuance of Securities.
Subject to the terms and conditions of this Agreement, GeoBio agrees to issue
and exchange the Shares for one hundred percent (100%) of the issued and
outstanding EP Stock held by the EP Security Holders.  All GeoBio
Shares will be issued directly to the EP Security Holders on the Closing Date
(as hereinafter defined), pursuant to the schedule set forth in Exhibit 1.1. Upon
Closing (defined in Section 7.1), GeoBio shall issue to the existing EP Security
Holders the Shares (ninety percent (90%) of the issued and outstanding shares of
GeoBio common stock at the time of the Closing (defined below) of this
Agreement).

    

    1.2           Exemption from Registration.
The parties hereto intend that all GeoBio common stock to be issued to the EP
Security Holders shall be exempt from the registration requirements of the
Securities Act of 1933, as amended (the “Securities Act”),
pursuant to Section 4(2) and/or Regulation D of the Securities Act and rules and
regulations promulgated thereunder.  In furtherance thereof, each of
the EP Security Holders will execute and deliver to GeoBio subscription
agreements for the Shares, a copy of which is attached as Exhibit 1.2, on the
Closing date of this Agreement (the “Closing
Date”).

    

     

    

    ARTICLE
II

    Representations
and Warranties of EP

    

    EP hereby represents and warrants to
GeoBio that:

    

    2.1           Organization. EP is a
corporation duly organized, validly existing and in good standing under the laws
of Nevada, has all necessary corporate powers to own its properties and to carry
on its business as now owned and operated by it, and is duly qualified to do
business and is in good standing in each of the states where its business
requires qualification.

    

    2.2           Capital. EP will deliver 100%
of its issued and outstanding stock, subscriptions, options, rights, warrants,
debentures, instruments, convertible securities or convertible preferred stock
and/or common stock equivalents, or other agreements or commitments obligating
EP to issue any additional EP Stock of any class, which shall equal thirty five
million (35,000,000) shares of common stock, on a fully diluted
basis.  There shall be no outstanding preferred stock of EP at the
time of the Closing.

    

    2.3           Subsidiaries. EP currently
does not own any subsidiaries.

    

    2.4           Directors and Executive
Officers. The names and titles of the directors and executive officers of
EP are as follows:

    

    

    
      	
              Name

            	 
      	
              Position

            
	
               

              Geoff
      Meagher

            	 
      	
               

              Chief
      Executive Officer, Director

            
	
               

              David
      J. Moore

            	 
      	
               

              President,
      Director

            
	
               

              Gary
      DeLaurentiis

            	 
      	
               

              Chief
      Operations Officer, Director

            
	
               

              David
      M. Otto

            	 
      	
               

              Secretary,
      Director

            
	 
      	 
      	 
      

    

    

    2.5           Financial Statements. Unless
otherwise provided herein as Exhibit 2.5, EP
represents that it shall have the ability to provide and shall produce, within
forty-five (45) days of Closing, financial statements consisting of a balance
sheet and a related statements of income and cash flow for (I) the prior two (2)
fiscal years (or for the period since inception of the Company, if less than two
years), (II) for the quarters subsequent to the most recent fiscal year and
(III) for the period subsequent to the most recent quarter if material changes
have occurred (the “EP
Financial
Statements”), which fairly represent the financial condition of EP as of
the respective dates and for the periods involved, and such statements shall be
prepared in accordance with generally accepted accounting principles
(GAAP).  The EP Financial Statements shall state Zero Dollars ($0) of
debt-related liabilities.

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    
       

    

    2.6           Absence of Changes. Since
December 31, 2008, there has not been any material change in the financial
condition or operations of EP, except as contemplated by this
Agreement.  As used throughout this Agreement, “material”
means:  Any change or effect (or development that, insofar as can be
reasonably foreseen, is likely to result in any change or effect) that causes
substantial increase or diminution in the business, properties, assets,
condition (financial or otherwise) or results of operations of a
party.  Taken as a whole, material change shall not include changes in
national or international economic conditions or industry conditions generally;
changes or possible changes in statutes and regulations applicable to a party;
or the loss of employees, customers or suppliers by a party as a direct or
indirect consequence of any announcement relating to this
transaction.

    

    2.7           Absence of Undisclosed
Liabilities. As of the Closing Date, EP shall not have any material debt,
liability or obligation of any nature, whether accrued, absolute, contingent or
otherwise, and whether due or to become due, that is not reflected in the EP
Liability Schedule, attached as Exhibit
2.7.

    

    2.8           Tax Returns. EP has filed all
federal, state and local tax returns required by law and has paid all taxes,
assessments and penalties due and payable. The provisions for taxes, if any,
reflected in Exhibit
2.8 are adequate for the periods indicated.  There are no
present disputes as to taxes of any nature payable by EP.

    

    2.9           Investigation of Financial
Condition. Without in any manner reducing or otherwise mitigating the
representations contained herein, GeoBio, its legal counsel and accountants
shall have the opportunity to meet with EP’s accountants and attorneys to
discuss the financial condition of EP during reasonable business hours and in a
manner that does not interfere with the normal operation of EP’s
business.  EP shall make available to GeoBio all books and records of
EP.

    

    2.10           Intellectual Property Rights.
EP owns or has the right to use all trademarks, service marks, trade names,
copyrights and patents material to its business.

    

    2.11           Compliance with Laws. To the
best of EP’s knowledge, EP has complied with, and is not in violation of,
applicable federal, state or local statutes, laws and regulations, including
federal and state securities laws, except where such non-compliance would not
have a material adverse impact upon its business or properties.

    

    2.12           Litigation. EP is not a
defendant in any suit, action, arbitration or legal, administrative or other
proceeding, or governmental investigation which is pending or, to the best
knowledge of EP, threatened against or affecting EP or its business, assets or
financial condition.  EP is not in default with respect to any order,
writ, injunction or decree of any federal, state, local or foreign court,
department, agency or instrumentality applicable to it.  EP is not
engaged in any material litigation to recover monies due to it.

     

    2.13           Authority. The Board of
Directors of EP has authorized the execution of this Agreement and the
consummation of the transactions contemplated herein, and EP has full power and
authority to execute, deliver and perform this Agreement, and this Agreement is
a legal, valid and binding obligation of EP and is enforceable in accordance
with its terms and conditions.  A majority of EP Security Holders have
agreed to and have approved the terms of this Agreement and the exchange of
securities contemplated hereby.

    

    2.14           Ability to Carry Out
Obligations. The execution and delivery of this Agreement by EP and the
performance by EP of its obligations hereunder in the time and manner
contemplated will not cause, constitute or conflict with or result in (a) any
breach or violation of any of the provisions of or constitute a default under
any license, indenture, mortgage, instrument, article of incorporation, bylaw,
or other agreement or instrument to which EP is a party, or by which it may be
bound, nor will any consents or authorizations of any party other than those
hereto be required, (b) an event that would permit any party to any agreement or
instrument to terminate it or to accelerate the maturity of any indebtedness or
other obligation of EP, or (c) an event that would result in the creation or
imposition of any lien, charge or encumbrance on any asset of EP.

    

    2.15           Full Disclosure. None of the
representations and warranties made by EP herein or in any exhibit, certificate
or memorandum furnished or to be furnished by EP, or on its behalf, contains or
will contain any untrue statement of material fact or omit any material fact the
omission of which would be misleading.

    

    2.16           Assets. EP’s assets shall be
fully included in Exhibit 2.16 attached
hereto no later than the Closing Date, and such assets are not subject to any
claims or encumbrances except as indicated in Schedule 2.16,
respectively.

    

    2.17           Material Contracts. A list of
EP’s material contracts shall be attached hereto as Exhibit 2.17 no later
than the Closing Date, and such contracts shall be made available for inspection
within five (5) days prior to Closing.

    

    2.18           Indemnification. EP agrees to
indemnify, defend and hold GeoBio harmless against and in respect of any and all
claims, demands, losses, costs, expenses, obligations, liabilities, damages,
recoveries and deficiencies, including interest, penalties and reasonable
attorney fees asserted by third parties against GeoBio which arise out of, or
result from (i) any breach by EP in performing any of its covenants or
agreements under this Agreement or in any schedule, certificate, exhibit or
other instrument furnished or to be furnished by EP under this Agreement, (ii) a
failure of any representation or warranty in this Article II or (iii) any untrue
statement made by EP in this Agreement.

     

    2.19           Criminal or Civil Acts. For the period of five
years prior to the execution of this Agreement, no executive officer, director
or principal stockholder of EP has been convicted of a felony crime, filed for
personal bankruptcy, been the subject of a Commission or NASD judgment or
decree, or is currently the subject to any investigation in connection with a
felony crime or Commission or NASD proceeding.

    

    2.20           Restricted
Securities.  EP and the EP Security Holders acknowledge that
all of the GeoBio Shares issued by GeoBio are restricted securities and none of
such securities may be sold or publicly traded except in accordance with the
provisions of the Securities Act.

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    

    

    ARTICLE
III

    Representations
and Warranties of GeoBio

    

    GeoBio represents and warrants to EP
the following to be true currently or shall be true as of the Closing
Date:

    

    3.1           Organization. GeoBio is a
corporation duly organized, validly existing and in good standing under the laws
of Colorado, has all necessary corporate powers to carry on its business, and is
duly qualified to do business and is in good standing in each of the states
where its business requires qualification.

     

    3.2           Capital. The authorized
capital stock of GeoBio:

    

    (a)
consists of two hundred million (200,000,000) shares of no par value common
stock, of which approximately forty four million (44,000,000) shares are
currently outstanding.  Zero (0) shares of no par value preferred
stock, five million (5,000,000) of which are authorized and none of which
currently are outstanding. All of the outstanding common stock is duly and
validly issued, fully paid and non-assessable. Currently, warrants to issue
approximately five million five hundred eighteen thousand five hundred fifty
three (5,518,553) shares of common stock remain outstanding.  There
are no other outstanding subscriptions, rights, debentures, instruments,
convertible securities or other agreements or commitments obligating GeoBio to
issue any additional shares of its capital stock of any class; and

    

    (b)
shall, on the Closing Date, consist approximately of five hundred million
(500,000,000) shares of capital stock, forty million (40,000,000) of which shall
be issued and outstanding, twenty five million (25,000,000) shares preferred
stock and none of which shall be issued and outstanding.  GeoBio shall
undertake all necessary steps to effect a recapitalization to implement this
capital structure.

    
       

    

    3.3           Subsidiaries. GeoBio does not
have any subsidiaries or own any interest in any other enterprise.

    

    3.4           Directors and
Officers.

    

    (a) The name
and title of the director and executive officer of GeoBio are as
follows:

    
      	
              Name

               

            	 
      	
              Position

            
	
              Gary
      M. DeLaurentiis

               

            	 
      	
              Director

            
	
              Alan
      Chaffee

               

            	 
      	
              Director

            
	
              David
      M. Otto

               

            	 
      	
              Director

            

    

    

    (b)           Upon
the Closing Date, GeoBio shall appoint up to two (2) additional EP designees to
the board of directors.

    

    3.5           Financial Statements. The
EDGAR database of the SEC contains Exhibit 3.5 hereto
the audited financial statements of GeoBio through the fiscal year ended
September 30, 2008 and quarterly statements through June 30, 2008 (the “GeoBio
Financial Statements”) These GeoBio Financial Statements have been
prepared in accordance with generally accepted accounting principles and
practices consistently followed by GeoBio throughout the period indicated, and
fairly present the financial position of GeoBio as of the date of the balance
sheet included in the GeoBio Financial Statements and the results of operations
for the period indicated. GeoBio shall bring its filings current within ninety
(90) days following the Closing Date.

    

    3.6           Financing.  No later
than ninety (90) days following the Closing Date, GeoBio shall have properly
secured and received financing in connection with this Agreement in the amount
of no less than Five Hundred Thousand U.S. Dollars ($500,000) (the “Financing”).  In the
event that GeoBio has not properly secured nor received the Financing, this
Agreement shall be immediately unwound, cancelled and terminated in accordance
with Section 9.16 herein below, and both parties returned to the state and
condition as of the date of this Agreement, less expenses incurred.

    

    3.7           Absence of Changes. Since June
30, 2008, there has not been any material change in the financial condition or
operations of GeoBio, except as publically filed with the Securities and
Exchange Commission or contemplated by this Agreement.  As used
throughout this Agreement, “material” means:  Any change or effect (or
development that, insofar as can be reasonably foreseen, is likely to result in
any change or effect) that causes substantial increase or diminution in the
business, properties, assets, condition (financial or otherwise) or results of
operations of a party.  Taken as a whole, material change shall not
include changes in national or international economic conditions or industry
conditions generally; changes or possible changes in statutes and regulations
applicable to a party; or the loss of employees, customers or suppliers by a
party as a direct or indirect consequence of any announcement relating to this
transaction.

     

    3.8           Absence of Undisclosed
Liabilities. As of the Closing Date, GeoBio shall not have any material
debt, liability or obligation of any nature, whether accrued, absolute,
contingent or otherwise, and whether due or to become due, that is not reflected
in the GeoBio Financial Statements.

    

    3.9           Tax Returns. GeoBio has, or as
of the Closing Date shall have, filed all federal, state and local tax returns
required by law and have paid all taxes, assessments and penalties due and
payable. The provisions for taxes, if any, reflected in Exhibit 3.8 are
adequate for the periods indicated.  There are no present disputes as
to taxes of any nature payable by GeoBio.

    

    3.10           Investigation of Financial
Condition. Without in any manner reducing or otherwise mitigating the
representations contained herein, EP, its legal counsel and accountants shall
have the opportunity to meet with GeoBio’s accountants and attorneys to discuss
the financial condition of GeoBio during reasonable business hours and in a
manner that does not interfere with the normal operation of GeoBio’s
business.  GeoBio shall make available to EP all books and records of
GeoBio.

    

    3.11           Intellectual Property Rights.
GeoBio has no trademarks, service marks, trade names, copyrights or filed
patents material to its business.

    

    3.12           Compliance with Laws. To the
best of GeoBio’s knowledge, GeoBio has complied with, and is not in violation
of, applicable federal, state or local statutes, laws and regulations, including
federal and state securities laws, except where such non-compliance would not
have a material adverse impact upon its business or properties.

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    

    3.13           Litigation. GeoBio is not a
defendant in any suit, action, arbitration or legal, administrative or other
proceeding, or governmental investigation which is pending or, to the best
knowledge of GeoBio, threatened against or affecting GeoBio or its business,
assets or financial condition.  GeoBio is not in default with respect
to any order, writ, injunction or decree of any federal, state, local or foreign
court, department, agency or instrumentality applicable to it.  GeoBio
is not engaged in any material litigation to recover monies due to
it.

     

    3.14           Authority. The Board of
Directors of GeoBio has authorized the execution of this Agreement and the
consummation of the transactions contemplated herein, and GeoBio has full power
and authority to execute, deliver and perform this Agreement, and this Agreement
is a legal, valid and binding obligation of GeoBio and is enforceable in
accordance with its terms and conditions.

     

    3.15           Ability to Carry Out
Obligations. The execution and delivery of this Agreement by GeoBio and
the performance by GeoBio of its obligations hereunder in the time and manner
contemplated will not cause, constitute or conflict with or result in (a) any
breach or violation of any of the provisions of or constitute a default under
any license, indenture, mortgage, instrument, article of incorporation, bylaw,
or other agreement or instrument to which GeoBio is a party, or by which it may
be bound, nor will any consents or authorizations of any party other than those
hereto be required, (b) an event that would permit any party to any agreement or
instrument to terminate it or to accelerate the maturity of any indebtedness or
other obligation of GeoBio, or (c) an event that would result in the creation or
imposition of any lien, charge or encumbrance on any asset of
GeoBio.

    

    3.16           Full Disclosure. None of the
representations and warranties made by GeoBio herein or in any exhibit,
certificate or memorandum furnished or to be furnished by GeoBio, or on its
behalf, contains or will contain any untrue statement of material fact or omit
any material fact the omission of which would be misleading.

    

    3.17           Assets. GeoBio assets are or
shall be prior to the Closing Date, fully included in Exhibit 3.5 and are
not subject to any claims or encumbrances except as indicated in Exhibit
3.5.

    

    3.18           Material Contracts. A list of
GeoBio’s material contracts are attached hereto as Exhibit 3.17, and
such contracts shall be made available for inspection within five (5) days prior
to Closing.

    

                   
3.19           Indemnification. GeoBio agrees
to indemnify, defend and hold EP harmless against and in respect of any and all
claims, demands, losses, costs, expenses, obligations, liabilities, damages,
recoveries and deficiencies, including interest, penalties and reasonable
attorney fees asserted by third parties against EP which arise out of, or result
from (i) any breach by GeoBio in performing any of its covenants or agreements
under this Agreement or in any schedule, certificate, exhibit or other
instrument furnished or to be furnished by GeoBio under this Agreement, (ii) a
failure of any representation or warranty in this Article III or (iii) any
untrue statement made by GeoBio in this Agreement.

    

    3.20           Criminal or Civil Acts. For the period of five (5)
years prior to the execution of this Agreement, no executive officer, director
or principal stockholder of GeoBio has been convicted of a felony crime, filed
for personal bankruptcy, been the subject of a Commission or Financial Industry
Regulatory Authority (FINRA) judgment or decree, or is currently the subject to
any investigation in connection with a felony crime or Commission or FINRA
proceeding.

     

    ARTICLE
IV

    Covenants
Prior to the Closing Date

     

                   
4.1           Investigative Rights. Prior to
the Closing Date, each party shall provide to the other party, and such other
party’s counsel, accountants, auditors and other authorized representatives,
full access during normal business hours and upon reasonable advance written
notice to all of each party’s properties, books, contracts, commitments and
records for the purpose of examining the same.  Each party shall
furnish the other party with all information concerning each party’s affairs as
the other party may reasonably request.  If during the investigative
period one party learns that a representation of the other party was not
accurate, no such claim may be asserted by the party so learning that a
representation of the other party was not accurate.

    

    4.2           Conduct of Business. Prior to
the Closing Date, each party shall conduct its business in the normal course and
shall not sell, pledge or assign any assets without the prior written approval
of the other party, except in the normal course of business.  Neither
party shall amend its Articles of Incorporation or Bylaws (except as may be
described in this Agreement), declare dividends, redeem or sell stock or other
securities.  Neither party shall enter into negotiations with any
third party or complete any transaction with a third party involving the sale of
any of its assets or the exchange of any of its common stock.

    

    4.3           Confidential Information.  Each party will
treat all non-public, confidential and trade secret information received from
the other party as confidential, and such party shall not disclose or use such
information in a manner contrary to the purposes of this
Agreement.  Moreover, all such information shall be returned to the
other party in the event this Agreement is terminated.

    

    4.4           Notice of Non-Compliance.  Each party shall
give prompt notice to the other party of any representation or warranty made by
it in this Agreement becoming untrue or inaccurate in any respect or the failure
by it to comply with or satisfy in any material respect any covenant, condition
or agreement to be complied with or satisfied by it under this
Agreement.

    

    ARTICLE
V

    Conditions
Precedent to GeoBio’s Performance

    

    5.1           Conditions. GeoBio’s
obligations hereunder shall be subject to the satisfaction at or before the
Closing Date of all the conditions set forth in this Article
V.  GeoBio may waive any or all of these conditions in whole or in
part without prior notice; provided, however, that no such waiver of a condition
shall constitute a waiver by GeoBio of any other condition of or any of GeoBio’s
other rights or remedies, at law or in equity, if EP shall be in default of any
of its representations, warranties or covenants under this
Agreement.

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    

    5.2           Accuracy of Representations.
Except as otherwise permitted by this Agreement, all representations and
warranties by EP in this Agreement or in any written statement that shall be
delivered to GeoBio by EP under this Agreement shall be true and accurate on and
as of the Closing Date as though made at that time.

    

    5.3           Performance. EP shall have
performed, satisfied and complied with all covenants, agreements and conditions
required by this Agreement to be performed or complied with by it on or before
the Closing Date.

    

    5.4           Absence of Litigation. No
action, suit or proceeding, including injunctive actions, before any court or
any governmental body or authority, pertaining to the transaction contemplated
by this Agreement or to its consummation, shall have been instituted or
threatened against EP on or before the Closing Date.

     

    5.5           Officer’s Certificate. EP
shall have delivered to GeoBio a certificate dated the Closing Date signed by
the Chief Executive Officer of EP certifying that each of the conditions
specified in this Article has been fulfilled and that all of the representations
set forth in Article II are true and correct as of the Closing
Date.

    

    5.6           Corporate Action. EP shall
have obtained the approval of the EP Security Holders for the transaction
contemplated by this Agreement.

    

    5.7           Acceptance of Financial
Statements. GeoBio shall have reviewed and in its sole discretion
accepted, prior to the Closing Date, the EP Financial Statements as set forth in
Exhibit
2.5.

    

    

    ARTICLE
VI

    Conditions
Precedent to EP’s Performance

    

    6.1           Conditions. EP’s obligations
hereunder shall be subject to the satisfaction at or before the Closing Date of
all the conditions set forth in this Article VI. EP may waive any or all of
these conditions in whole or in part without prior notice; provided, however,
that no such waiver of a condition shall constitute a waiver by EP of any other
condition of or any of EP’s rights or remedies, at law or in equity, if GeoBio
shall be in default of any of its representations, warranties or covenants under
this Agreement.

    

    6.2           Accuracy of Representations.
Except as otherwise permitted by this Agreement, all representations and
warranties by GeoBio in this Agreement or in any written statement that shall be
delivered to EP by GeoBio under this Agreement shall be true and accurate on and
as of the Closing Date as though made at that time.

    

    6.3           Performance. GeoBio shall have
performed, satisfied and complied with all covenants, agreements and conditions
required by this Agreement to be performed or complied with by it on or before
the Closing Date.

    

    6.4           Absence of Litigation. No
action, suit or proceeding before any court or any governmental body or
authority, pertaining to the transaction contemplated by this Agreement or to
its consummation, shall have been instituted or threatened against GeoBio on or
before the Closing Date.

    

    6.5           Officer’s Certificate. GeoBio
shall have delivered to EP a certificate dated the Closing Date signed by the
Chief Executive Officer of GeoBio certifying that each of the conditions
specified in this Article has been fulfilled and that all of the representations
set forth in Article III are true and correct as of the Closing
Date.

    

    6.6           Payment of Liabilities. On or before the Closing
Date, GeoBio shall have paid any outstanding obligations and liabilities of
GeoBio through the Closing Date, including obligations created subsequent to the
execution of this Agreement.

    

    6.7           Directors of GeoBio. On the Closing Date,
the Board of Directors of GeoBio shall appoint up to two (2) designees of EP to
GeoBio Board of Directors.

    

    6.8           Officers of GeoBio. Concurrent to this
Agreement, the Board of Directors of GeoBio shall execute an employment
agreements naming Geoff Meagher to the position of Chief Executive Officer,
David J. Moore to the position of President, Gary DeLaurentiis to the position
of Chief Operations Officer and David M. Otto to the position of Secretary of
GeoBio.  Alan Chaffee shall remain the Chief Financial Officer of
GeoBio.

    

    ARTICLE
VII

    Closing

    

    7.1           Closing. The closing of this
Agreement shall be held at the offices of The Otto Law Group, PLLC, or at any
mutually agreeable place within ninety (90) days of the mutual execution of this
Agreement, unless extended by mutual agreement.  At the
closing:

    

    (a) EP shall
deliver to GeoBio (i) copies of Exhibit 1.2 executed
by all of the EP Security Holders, (ii) an assignment of all of the EP Stock to
GeoBio, (iii) the officer’s certificate described in Section 5.5, (iv) signed
minutes of its directors approving this Agreement.

    

    (b) GeoBio
shall deliver to EP (i) certificates representing the Shares issued in the names
of the EP Security Holders, (ii) the officer’s certificate described in Section
6.5, and (iii) signed minutes of its directors approving this
Agreement.

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    ARTICLE
VIII

    Covenants
Subsequent to the Closing Date

    

    8.1           Registration and Listing. Following the Closing Date,
GeoBio shall:

    

    (a) Seek,
secure and receive the Financing in accordance with Section 3.6
above;

     

    (b) Comply
with the Form 8-K requirements of the Securities Exchange Act of 1934 (the
“Exchange
Act”), including the timely preparation and filing of audited financial
statements as required by Form 8-K; and

     

    (c) Clear any
Exchange Act Rule 144 sales of GeoBio common stock offered by any GeoBio common
stockholder including affiliates or former affiliates of GeoBio within
forty-eight (48) hours of the filing of the Notice of Sale pursuant to Rule
144.

     

                  
8.2   Corporate
Action.  GeoBio shall file the required documents and take the
required actions to change its name to “EnviroPlastics Corporation” or to such
other name as deemed acceptable to the directors and management of GeoBio,
within thirty (30) days following the Closing.

    
       

    

    

    ARTICLE
IX

    Miscellaneous

    

    9.1           Captions and Headings. The
article and Section headings throughout this Agreement are for convenience and
reference only and shall not define, limit or add to the meaning of any
provision of this Agreement.

    

    9.2           No Oral Change. This Agreement
and any provision hereof may not be waived, changed, modified or discharged
orally, but only by an agreement in writing signed by the party against whom
enforcement of any such waiver, change, modification or discharge is
sought.

    

    9.3           Non-Waiver. The failure of any
party to insist in any one or more cases upon the performance of any of the
provisions, covenants or conditions of this Agreement or to exercise any option
herein contained shall not be construed as a waiver or relinquishment for the
future of any such provisions, covenants or conditions.  No waiver by
any party of one breach by another party shall be construed as a waiver with
respect to any other subsequent breach.

    

    9.4           Time of Essence. Time is of
the essence of this Agreement and of each and every provision
hereof.

    

    9.5           Entire Agreement. This
Agreement contains the entire Agreement and understanding between the parties
hereto and supersedes all prior agreements and understandings.

    

    9.6           Choice of Law. This Agreement
and its application shall be governed by the laws of the State of
Washington.

    

    9.7           Counterparts. This Agreement
may be executed simultaneously in one or more counterparts, each of which shall
be deemed an original, but all of which together shall constitute one and the
same instrument.

    

    9.8           Notices. All notices,
requests, demands and other communications under this Agreement shall be in
writing and shall be deemed to have been duly given on the date of service if
served personally on the party to whom notice is to be given, or on the third
day after mailing if mailed to the party to whom notice is to be given, by first
class mail, registered or certified, postage prepaid, and properly addressed as
follows:

    

    
      	
              GeoBio
      Energy, Inc.:

            	 
      	
              GeoBio
      Energy, Inc

              c/o The Otto Law Group,
      PLLC

              601
      Union Street

              Suite
      4500

              Seattle,
      WA 98101

              Attn:  David
      M. Otto, Director

            
	
               

               

              EnviroPlastics
      Corporation:

            	 
      	
               

               

              8619
      N. Division Street

              Suite
      A

              Spokane,
      WA 99208

              Attn:
      Geoff Meagher, CEO

            
	
               

               

              With
      a copy to:

            	 
      	
               

               

              The
      Otto Law Group, PLLC601 Union Street, Suite 4500

              Seattle,
      Washington 98101

              Attn:
      David Otto

            

    

    

    

    9.9           Binding Effect. This Agreement
shall inure to and be binding upon the heirs, executors, personal
representatives, successors and assigns of each of the parties to this
Agreement.

    

    9.10           Mutual Cooperation. The
parties hereto shall cooperate with each other to achieve the purpose of this
Agreement and shall execute such other and further documents and take such other
and further actions as may be necessary or convenient to effect the transaction
described herein.

    

    9.11           Finders. There are no finders
in connection with this transaction.

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    

    9.12           Announcements.  The
parties will consult and cooperate with each other as to the timing and content
of any public announcements regarding this Agreement.

    

    9.13           Expenses. Each party will bear
their own expenses, including legal fees incurred in connection with this
Agreement.  The EP Security Holders shall not be responsible for any
costs incurred in connection with the transaction contemplated by this
Agreement.

    

    9.14           Survival of Representations and
Warranties. The representations, warranties, covenants and agreements of
the parties set forth in this Agreement or in any instrument, certificate,
opinion or other writing providing for in it, shall survive the Closing
Date.

    

    9.15           Exhibits. As of the execution
hereof, the parties have provided each other with the exhibits described
herein.  Any material changes to the exhibits shall be immediately
disclosed to the other party.

     

    9.16           Unwinding, Termination, Amendment and
Waiver.

    

    (a) Undwinding.                                At
any time whatsoever within ninety (90) days following the Closing Date of this
Agreement, this Agreement may be cancelled and unwound by EP should GeoBio not
prove able to provide the Financing in accordance with Section 3.6 above, and/or
the proper and necessary due diligence materials, information and documents
requested in this Agreement and its Exhibits attached.  In the event
of cancellation and unwinding of this Agreement by either of the Parties, as
provided herein, this Agreement shall forthwith become void and have no effect,
without any liability or obligation on the part of either of the Parties, and
such cancellation and unwinding shall not relieve any party hereto for any
intentional breach prior to such cancellation and unwinding by a party hereto of
any of its representations or warranties or any of its covenants or agreements
set forth in this Agreement.  In the event of cancellation and
unwinding of this Agreement, the Parties agree to make a good faith effort to
return all consideration tendered and delivered by the other Party.

    

    (b) Termination.  This
Agreement may be terminated at any time prior to the Closing Date, whether
before or after approval of matters presented in connection with the share
exchange by the stockholders of GeoBio or by the members of EP:

    

    (1)           By
mutual written consent of EP and GeoBio;

    

    (2)           By
either EP or GeoBio;

    

    
      	
               
      

            	
              (i)

            	
              If
      any court of competent jurisdiction or any governmental, administrative or
      regulatory authority, agency or body shall have issued an order, decree or
      ruling or taken any other action permanently enjoining, restraining or
      otherwise prohibiting the transactions contemplated by this Agreement;
      or

            

    

    

    
      	
               
      

            	
              (ii)

            	
              If
      the transaction shall not have been consummated on or before within thirty
      (30) days following mutual execution of this Agreement, unless the failure
      to consummate the transaction is the result of a material breach of this
      Agreement by the party seeking to terminate this
  Agreement.

            

    

    

    (3)           By
EP, if GeoBio breaches any of its representations or warranties hereof or fails
to perform in any material respect any of its covenants, agreements or
obligations under this Agreement; and

    

    (4)           By
GeoBio, if EP breaches any of its representations or warranties hereof or fails
to perform in any material respect any of its covenants, agreements or
obligations under this Agreement.

    

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

    (c)           Effect of
Termination.  In the event of termination of this Agreement by
either GeoBio or EP, as provided herein, this Agreement shall forthwith become
void and have no effect, without any liability or obligation on the part of EP
or GeoBio, and such termination shall not relieve any party hereto for any
intentional breach prior to such termination by a party hereto of any of its
representations or warranties or any of its covenants or agreements set forth in
this Agreement.

    

    (d)           Extension;
Waiver.  At any time prior to the Closing Date, the parties
may, to the extent legally allowed, (a) extend the time for the performance of
any of the obligation of the other acts of the other parties, (b) waive any
inaccuracies in the representations and warranties contained herein or in any
document delivered pursuant hereto or waive compliance with any of the
agreements or conditions contained herein.  Any agreement on the part
of a party to any such extension or waiver shall be valid only if set forth in
an instrument in writing signed on behalf of such party.  The failure
of any party to this Agreement to assert any of its rights under this Agreement
or otherwise shall not constitute a waiver of such rights.

    

    (e)           Procedure for Unwinding, Termination,
Amendment, Extension or Waiver.  An unwinding of this
Agreement, a termination of this Agreement, an amendment of this Agreement or an
extension or waiver shall, in order to be effective, require in the case of EP
or GeoBio, action by its respective Board of Directors or the duly authorized
designee of such Board of Directors.

    

    [Remainder of Page
Intentionally Blank; Signature Page Follows]

    In witness whereof, the parties have
executed this Agreement concerning the exchange of securities on the date
indicated above.

    

    

    

    
      	
              GEOBIO
      ENERGY, INC.

            	 	 

    

    

    

    By:                                                      

    

               _______________________

    Director

    

    

    

    

    

    

    ENVIROPLASTICS
CORPORATION    

    

    

    

    By:                                                      

    

    _______________________

    
 

    Chief
Executive Officer,
Director                                                                                                           

    

    

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    

    EXHIBIT
1.1

    

    EP
Security Holders

    

    EXHIBIT
1.2

    

    EP
Subscription Agreements

    EXHIBIT
2.5

    

    Financial
Statements for EP (if available)

    EXHIBIT
2.7

    

    EP
Liability Schedule

    EXHIBIT
2.8

    

    Provisions for taxes (if
any)

    EXHIBIT
2.16

    

    Assets
of EP

    EXHIBIT
2.17

    

    Material
Contractsof EP

    EXHIBIT
3.5

    

    Financial
Statements for GeoBio

    EXHIBIT
3.8

    

    GeoBio
provisions for Tax Returns(if any)

    EXHIBIT 3.17

    

    Material
Contracts for GeoBioFiled by Bowne Pure Compliance

Exhibit 10.1

WOLVERINE WORLD WIDE, INC.

1993 STOCK INCENTIVE PLAN

SECTION 1

Establishment of Plan; Purpose of Plan

1.1 Establishment of Plan. The Company hereby establishes the 1993 STOCK INCENTIVE
PLAN (the “Plan”) for its corporate, divisional, and Subsidiary officers and other key employees.
The Plan permits the grant and award of Stock Options, Restricted Stock, and Stock Awards.

1.2 Purpose of Plan. The purpose of the Plan is to provide officers and key
management employees of the Company, its divisions, and its Subsidiaries with an increased
incentive to make significant and extraordinary contributions to the long-term performance and
growth of the Company and its Subsidiaries, to join the interests of officers and key employees
with the interests of the Company’s stockholders through the opportunity for increased stock
ownership, and to attract and retain officers and key employees of exceptional ability. The Plan is
further intended to provide flexibility to the Company in structuring long-term incentive
compensation to best promote the foregoing objectives.

SECTION 2

Definitions

The following words have the following meanings unless a different meaning is plainly required
by the context:

2. 1 “Act” means the Securities Exchange Act of 1934, as amended.

2.2 “Board” means the Board of Directors of the Company.

2.3 “Change in Control” means (a) the sale, lease, exchange, or other transfer of
substantially all of the Company’s assets (in one transaction or in a series of related
transactions) to, or the merger or consolidation of the Company with, a corporation that is not
controlled by the Company; or (b) a change in control of the Company of a nature that would be
required to be reported in response to Item 6(e) of Schedule 14A of Regulation l4A promulgated
under the Act: provided that, without limitation, such a change in control shall be deemed to have
occurred if (i) any “person” (as such term is used in Sections 13(d) and 14(d)(2) of the Act),
other than a Subsidiary or any employee benefit plan of the Company or a Subsidiary or any entity
holding Common Stock pursuant to the terms of any such employee benefit plan, is or becomes the
beneficial owner (as defined in Rule l3(d)-3 under the Act), directly or indirectly, of securities
of the Company representing twenty percent (20%) or more of the combined voting power of the
Company’s then outstanding securities; or (ii) during any period of two
consecutive years, individuals who at the beginning of such period constitute the Board cease for
any reason to constitute at least a majority of the Board, unless the election, or nomination for
election by the Company’s stockholders, of each new director was approved by a vote of at least
two-thirds (2/3) of the directors then still in office who were directors at the beginning of the
period.

 

 

 

2.4 “Code” means the Internal Revenue Code of 1986, as amended.

2.5 “Committee” means the Compensation Committee of the Board or such other committee as the
Board shall designate to administer the Plan. The Committee shall consist of at least two members
of the Board, and all of its members shall be “disinterested persons” as defined in Rule 16b-3
under the Act.

2.6 “Common Stock” means the Common Stock of the Company, par value $1 per share.

2.7 “Company” means Wolverine World Wide, Inc., a Delaware corporation, and its successors and
assigns.

2.8 “Incentive Award” means the award or grant of a Stock Option, Restricted Stock, or Stock
Award to a Participant pursuant to the Plan.

2.9 “Market Value” shall equal the closing market price of shares of Common Stock reported on
the New York Stock Exchange (or any successor exchange that is the primary stock exchange for
trading of Common Stock) on the date of grant, exercise or vesting, as applicable, or if the New
York Stock Exchange (or any such successor) is closed on that date, the last preceding date on
which the New York Stock Exchange (or any such successor) was open for trading and on which shares
of Common Stock were traded.

2.10 “Participant” means a corporate officer, divisional officer, or other key employee of the
Company, its divisions, or its Subsidiaries who the Committee determines is eligible to participate
in the Plan and who is designated to be granted an Incentive Award under the Plan.

2. 11 “Restricted Period” means the period of time during which Restricted Stock awarded under
the Plan is subject to restrictions. The Restricted Period may differ among Participants and may
have different expiration dates with respect to shares of Common Stock covered by the same
Incentive Award.

2.12 “Restricted Stock” means Common Stock awarded to a Participant pursuant to Section 6 of
the Plan.

2.13 “Retirement” means the voluntary termination of all employment by a Participant after the
Participant has attained 60 years of age, or such other age as shall be determined by the Committee
in its sole discretion or as otherwise may be set forth in the Incentive Award agreement or other
grant document with respect to a Participant and a particular Incentive Award.

2.14 “Stock Award” means an award of Common Stock awarded to a Participant pursuant to Section
7 of the Plan.

2.15 “Stock Option” means the right to purchase Common Stock at a stated price for a specified
period of time. For purposes of the Plan, a Stock Option may be either an incentive stock option
within the meaning of Section 422(b) of the Code or a nonqualified stock option.

 

2

 

2.16 “Subsidiary” means any corporation or other entity of which fifty percent (50%) or more
of the outstanding voting stock or voting ownership interest is directly or indirectly owned or
controlled by the Company or by one or more Subsidiaries of the Company.

SECTION 3

Administration

3.1 Power and Authority. The Committee shall administer the Plan, shall have full
power and authority to interpret the provisions of the Plan, and shall have full power and
authority to supervise the administration of the Plan. All determinations, interpretations, and
selections made by the Committee regarding the Plan shall be final and conclusive. The Committee
shall hold its meetings at such times and places as it deems advisable. Action may be taken by a
written instrument signed by a majority of the members of the Committee, and any action so taken
shall be fully as effective as if it had been taken at a meeting duly called and held. The
Committee shall make such rules and regulations for the conduct of its business as it deems
advisable. The members of the Committee shall not be paid any additional fees for their services.

3.2 Grants or Awards to Participants. In accordance with and subject to the
provisions of the Plan, the Committee shall have the authority to determine all provisions of
Incentive Awards as the Committee may deem necessary or desirable and as are consistent with the
terms of the Plan, including, without limitation, the following: (a) the persons who shall be
selected as Participants; (b) the nature and extent of the Incentive Awards to be made to each
Participant (including the number of shares of Common Stock to be subject to each Incentive Award,
any exercise price, the manner in which an Incentive Award will vest or become exercisable, and the
form of payment for the Incentive Award); (c) the time or times when Incentive Awards will be
granted; (d) the duration of each Incentive Award; and (e) the restrictions and other conditions to
which payment or vesting of Incentive Awards may be subject.

3.3 Amendments or Modifications of Awards. The Committee shall have the authority to
amend or modify the terms of any outstanding Incentive Award in any manner, provided that the
amended or modified terms are not prohibited by the Plan as then in effect and provided such
actions do not cause an Incentive Award not already subject to Section 409A of the Code to become
subject to Section 409A of the Code, unless the Committee expressly determines to make an Incentive
Award subject to Section 409A of the Code, including, without limitation, the authority to: (a)
modify the number of shares or other terms and conditions of an Incentive Award; provided that any
increase in the number of shares of an Incentive Award other than pursuant to Section 4.2 shall be
considered to be a new grant with respect to such additional shares for purposes of Section 409A of
the Code and such new grant shall be made at Market Value on the
date of grant; (b) extend the term of an Incentive Award to a date that is no later than the
earlier of the latest date upon which the Incentive Award could have expired by its terms under any
circumstances or the 10th anniversary of the date of grant (for purposes of clarity, as
permitted under Section 409A of the Code, if the term of a Stock Option is extended at a time when
the Stock Option price equals or exceeds the Market Value, it will not be an extension of the term
of the Stock Option, but instead will be treated as a modification of the Stock Option and a new
Stock Option will be treated as having been granted); (c) accelerate the exercisability or vesting
or otherwise terminate any restrictions relating to an Incentive Award; (d) accept the surrender of
any outstanding Incentive Award or (e) to the extent not previously exercised or vested, authorize
the grant of new Incentive Awards in substitution for surrendered Incentive Awards; provided,
however, that such grant of new Incentive Awards shall be considered to be a new grant for purposes
of Section 409A of the Code and such new grant shall be made at Market Value on the date of the new
grant.

 

3

 

3.4 Indemnification of Committee Members. Each person who is or shall have been a
member of the Committee shall be indemnified and held harmless by the Company from and against any
cost, liability, or expense imposed or incurred in connection with such person’s or the Committee’s
taking or failing to take any action under the Plan. Each such person shall be justified in relying
on information furnished in connection with the Plan’s administration by any appropriate person or
persons.

SECTION 4

Shares Subject to the Plan

4.1 Number of Shares. Subject to adjustment as provided in subsection 4.2 of the
Plan, a maximum of 350,000 shares of Common Stock (not including any adjustments occurring before
the date of this amendment pursuant to Section 4.2) shall be available for Incentive Awards under
the Plan. Such shares shall be authorized and may be either unissued or treasury shares.

4.2 Adjustments. If the number of shares of Common Stock outstanding changes by
reason of a stock dividend, stock split, recapitalization, merger, consolidation, combination,
exchange of shares, or any other change in the corporate structure or shares of the Company, the
number and kind of securities subject to and reserved under the Plan, together with applicable
exercise prices, shall be appropriately adjusted. No fractional shares shall be issued pursuant to
the Plan, and any fractional shares resulting from adjustments shall be eliminated from the
respective Incentive Awards, with an appropriate cash adjustment for the value of any Incentive
Awards eliminated. If an Incentive Award is cancelled, surrendered, modified, exchanged for a
substitute Incentive Award, or expires or terminates during the term of the Plan but prior to the
exercise or vesting of the Incentive Award in full, the shares subject to but not delivered under
such Incentive Award shall be available for other Incentive Awards.

SECTION 5

Stock Options

5.1 Grant. A Participant may be granted one or more Stock Options under the Plan.
Stock Options shall be subject to such terms and conditions, consistent with the other provisions
of the Plan, as may be determined by the Committee in its sole discretion. In addition, the
Committee may vary, among Participants and among Stock Options granted to the same Participant, any
and all of the terms and conditions of the Stock Options granted under the Plan. The Committee
shall have complete discretion in determining the number of Stock Options granted to each
Participant. The Committee may designate whether or not a Stock Option is to be considered an
incentive stock option as defined in Section 422(b) of the Code.

 

4

 

5.2 Stock Option Agreements. Stock Options shall be evidenced by Stock Option
agreements containing such terms and conditions, consistent with the provisions of the Plan, as the
Committee shall from time to time determine. Unless a Stock Option agreement provides otherwise,
Stock Options shall be subject to the terms and conditions set forth in this Section.

5.3 Stock Option Price. The per share Stock Option price shall be determined by the
Committee; provided, however, that the per share Stock Option price shall be equal to or greater
than one hundred percent (100%) of the Market Value on the date of grant.

5.4 Medium and Time of Payment. The exercise price for each share purchased pursuant
to a Stock Option granted under the Plan shall be payable in cash or, if the Committee consents, in
shares of Common Stock (including Common Stock to be received upon a simultaneous exercise) or
other consideration substantially equivalent to cash. To the extent any such amendment would not
cause a Stock Option to become subject to Section 409A of the Code, unless the Committee expressly
determines to make a Stock Option subject to Section 409A of the Code, the time and terms of
payment may be amended with the consent of a Participant before or after exercise of a Stock
Option, but such amendment shall not reduce the Stock Option price. The Committee may from time to
time authorize payment of all or a portion of the Stock Option price in the form of a promissory
note or installments according to such terms as the Committee may approve. The Board may restrict
or suspend the power of the Committee to permit such loans and may require that adequate security
be provided.

5.5 Stock Options Granted to Ten Percent Stockholders. No Stock Option granted to any
Participant who at the time of such grant owns, together with stock attributed to such Participant
under Section 424(d) of the Code, more than ten percent (10%) of the total combined voting power of
all classes of stock of the Company or any of its Subsidiaries may be designated as an incentive
stock option, unless such Stock Option provides an exercise price equal to at least one hundred ten
percent (110%) of the Market Value of the Common Stock and the exercise of the Stock Option after
the expiration of five years from the date of grant of the Stock Option is prohibited by its terms.

5.6 Limits on Exercisability. Stock Options shall be exercisable for such periods as
may be fixed by the Committee, not to exceed 10 years from the date of grant. At the time of the
exercise of a Stock Option, the holder of the Stock Option, if requested by the Committee, must
represent to the Company that the shares are being acquired for
investment and not with a view to the distribution thereof. The Committee may in its discretion
require a Participant to continue the Participant’s service with the Company and its Subsidiaries
for a certain length of time prior to a Stock Option becoming exercisable and may eliminate such
delayed vesting provisions. No Stock Option issued to officers and employees subject to Section 16
of the Act shall be exercisable during the first six months of its term.

 

5

 

5.7 Restrictions on Transferability.

(a) General. Unless the Committee otherwise consents or unless the Stock
Option agreement or grant provide otherwise: (i) no Stock Options granted under the Plan
may be sold, exchanged, transferred, pledged, assigned, or other wise alienated or
hypothecated except by will or the laws of descent and distribution; and (ii) all Stock
Options granted to a Participant shall be exercisable during the Participant’s lifetime
only by such Participant, his guardian, or legal representative.

(b) Other Restrictions. The Committee may impose other restrictions on any
 shares of Common Stock acquired pursuant to the exercise of a Stock Option under the Plan
as the Committee deems advisable, including, without limitation, restrictions under
applicable federal or state securities laws.

5.8 Termination of Employment or Officer Status.

(a) General. If a Participant ceases to be employed by or an officer of the
Company or one of its Subsidiaries for any reason other than the Participant’s death,
disability, Retirement, or termination for cause, the Participant may exercise his Stock
Options only for a period of three months after such termination of employment or officer
status, but only to the extent the Participant was entitled to exercise the Stock Options
on the date of termination, unless the Committee otherwise consents or the terms of the
Stock Option agreement or grant provide otherwise. For purposes of the Plan, the following
shall not be deemed a termination of employment or officer status: (i) a transfer of an
employee from the Company to any Subsidiary; (ii) a leave of absence, duly authorized in
writing by the Company, for military service or for any other purpose approved by the
Company if the period of such leave does not exceed 90 days; (iii) a leave of absence in
excess of 90 days, duly authorized in writing by the Company, provided that the employee’s
right to reemployment is guaranteed either by statute or contract; or (iv) a termination of
employment with continued service as an officer.

(b) Death. If a Participant dies either while an employee or officer of the
Company or one of its Subsidiaries or after the termination of employment other than for
cause but during the time when the Participant could have exercised a Stock Option under
the Plan, the Stock Option issued to such Participant shall be exercisable by the personal
representative of such Participant or other successor to the interest of the Participant
for one year after the Participant’s death, but only to the extent that the Participant was
entitled to exercise the Stock Option on the date of death or termination of employment,
whichever first
occurred, unless the Committee otherwise consents or the terms of the Stock Option
agreement or grant provide otherwise.

(c) Disability. If a Participant ceases to be an employee or officer of the
Company or one of its Subsidiaries due to the Participant’s disability, the Participant may
exercise a Stock Option for a period of one year following such termination of employment,
but only to the extent that the Participant was entitled to exercise the Stock Option on
the date of such event, unless the Committee otherwise consents or the terms of the Stock
Option agreement or grant provide otherwise.

 

6

 

(d) Participant Retirement. If a Participant Retires as an employee or
officer of the Company or one of its Subsidiaries, any Stock Option granted under the Plan
may be exercised during the remaining term of the Stock Option, unless the terms of the
Stock Option agreement or grant provide otherwise.

(e) Termination for Cause. If a Participant is terminated for cause, the
Participant shall have no further right to exercise any Stock Option previously granted.

SECTION 6

Restricted Stock

6.1 Grant. A Participant may be granted Restricted Stock under the Plan. Restricted
Stock shall be subject to such terms and conditions, consistent with the other provisions of the
Plan, as shall be determined by the Committee in its sole discretion. The Committee may impose such
restrictions or conditions, consistent with the provisions of the Plan, to the vesting of
Restricted Stock as it deems appropriate.

6.2 Restricted Stock Agreements. Awards of Restricted Stock shall be evidenced by
Restricted Stock agreements containing such terms and conditions, consistent with the provisions of
the Plan, as the Committee shall from time to time determine. Unless a Restricted Stock agreement
provides otherwise, Restricted Stock Awards shall be subject to the terms and conditions set forth
in this Section 6.

6.3 Termination of Employment or Officer Status.

(a) General. In the event of termination of employment or officer status
during the Restricted Period for any reason other than death, disability, Retirement, or
termination for cause, then any shares of Restricted Stock still subject to restrictions at
the date of such termination shall automatically be forfeited and returned to the Company;
provided, however, that in the event of a voluntary or involuntary termination of the
employment or officer status of a Participant by the Company, the Committee may, in its
sole discretion, waive the automatic forfeiture of any or all such shares of Restricted
Stock and/or may add such new restrictions to such shares of Restricted Stock as it deems
appropriate. For purposes of the Plan, the following shall not be deemed a termination of
employment or officer status: (i) a transfer of an employee from the Company to any
Subsidiary; (ii) a leave of absence, duly authorized in writing by the Company, for
military service or for any other purpose approved by the Company if the period of such
leave does not exceed 90 days; (iii) a leave of absence in
excess of 90 days, duly authorized in writing by the Company, provided that the employee’s
right to reemployment is guaranteed either by statute or contract; and (iv) a termination
of employment with continued service as an officer.

 

7

 

(b) Death, Retirement Disability. Unless the Committee otherwise consents or
unless the terms of the Restricted Stock agreement or grant provide otherwise, in the event
a Participant terminates his employment with the Company because of death, disability, or
Retirement during the Restricted Period, the restrictions applicable to the shares of
Restricted Stock shall terminate automatically with respect to that number of shares
(rounded to the nearest whole number) equal to the total number of shares of Restricted
Stock granted to such Participant multiplied by the number of full months that have elapsed
since the date of grant divided by the maximum number of full months of the Restricted
Period. All remaining shares shall be forfeited and returned to the Company; provided,
however, that the Committee may, in its sole discretion, waive the restrictions remaining
on any or all such remaining shares of Restricted Stock either before or after the death,
disability, or Retirement of the Participant.

(c) Termination for Cause. If a Participant’s employment is terminated for
cause, the Participant shall have no further right to exercise or receive any Restricted
Stock, and all Restricted Stock still subject to restrictions at the date of such
termination shall automatically be forfeited and returned to the Company.

6.4 Restrictions on Transferability.

(a) General. Unless the Committee otherwise consents or unless the terms of
the Restricted Stock agreement or grant provide otherwise: (i) shares of Restricted Stock
shall not be sold, exchanged, transferred, pledged, assigned, or otherwise alienated or
hypothecated during the Restricted Period except by will or the laws of descent and
distribution; and (ii) all rights with respect to Restricted Stock granted to a Participant
under the Plan shall be exercisable during the Participant’s lifetime only by such
Participant, his guardian, or legal representative.

(b) Other Restrictions. The Committee may impose other restrictions on any
 shares of Common Stock acquired pursuant to an award of Restricted Stock under the Plan as
the Committee deems advisable, including, without limitation, restrictions under applicable
federal or state securities laws.

6.5 Legending of Restricted Stock. Any certificates evidencing shares of
Restricted Stock awarded pursuant to the Plan shall bear the following legend:

The shares represented by this certificate were issued subject to certain restrictions
under the Wolverine World Wide, Inc. 1993 Stock Incentive Plan (the “Plan”). A copy of the
Plan is on file in the office of the Secretary of the Company. This certificate is held
subject to the terms and conditions contained in a restricted stock agreement that includes
a prohibition against the sale or transfer of the stock represented by this certificate
except in compliance with that agreement, and that provides for forfeiture upon certain
events.

6.6 Representations and Warranties. A Participant who is awarded Restricted Stock
shall represent and warrant that the Participant is acquiring the Restricted Stock for the
Participant’s own account and investment and without any intention to resell or redistribute the
Restricted Stock. The Participant shall agree not to resell or distribute such Restricted Stock
after the Restricted Period except upon such conditions as the Company may reasonably specify to
ensure compliance with federal and state securities laws.

 

8

 

6.7 Rights as a Stockholder. A Participant shall have all voting, dividend,
liquidation, and other rights with respect to Restricted Stock held of record by such Participant
as if the Participant held unrestricted Common Stock; provided, however, that the unvested portion
of any award of Restricted Stock shall be subject to any restrictions on transferability or risks
of forfeiture imposed pursuant to subsections 6. 1 and 6.4 of the Plan. Unless the Committee
otherwise determines or unless the terms of the Restricted Stock agreement or grant provide
otherwise, any noncash dividends or distributions paid with respect to shares of unvested
Restricted Stock shall be subject to the same restrictions as the shares to which such dividends or
distributions relate. Any dividend payment with respect to Restricted Stock shall be made no later
than the end of the calendar year in which the dividends are paid to stockholders, or, if later,
the 15th day of the third month following the date the dividends are paid to
stockholders.

SECTION 7

Stock Awards

7.1 Grant. A Participant may be granted one or more Stock Awards under the Plan in
lieu of, or as payment for, the rights of a Participant under any other compensation plan, policy,
or program of the Company or its Subsidiaries. Stock Awards shall be subject to such terms and
conditions, consistent with the other provisions of the Plan, as may be determined by the Committee
in its sole discretion. Notwithstanding the previous sentence, the shares of stock subject to
Stock Awards shall be issued no later than the 15th day of the third month after the end
of the calendar year in which the award is granted.

7.2 Rights as a Stockholder. A Participant shall have all voting, dividend.
liquidation, and other rights with respect to shares of Common Stock issued to the Participant as a
Stock Award under this Section 7 upon the Participant becoming the holder of record of the Common
Stock granted pursuant to such Stock Awards; provided, however, that the Committee may impose such
restrictions on the assignment or transfer of Common Stock awarded pursuant to a Stock Award as it
deems appropriate. Any dividend payment with respect to Stock Awards shall be made no later than
the end of the calendar year in which the dividends are paid to stockholders, or, if later, the
15th day of the third month following the date the dividends are paid to stockholders.

SECTION 8

Change in Control

8.1 Acceleration of Vesting. If a Change in Control of the Company shall occur, then,
unless the Committee or the Board otherwise determines with respect to one or more Incentive
Awards, without action by the Committee or the Board (a) all
outstanding Stock Options shall become immediately exercisable in full and shall remain exercisable
during the remaining term thereof, regardless of whether the Participants to whom such Stock
Options have been granted remain in the employ or service of the Company or any Subsidiary; and (b)
all other outstanding Incentive Awards shall become immediately fully vested and nonforfeitable.

 

9

 

8.2 Cash Payment for Stock Options. If a Change in Control of the Company shall
occur, then the Committee, in its sole discretion, and without the consent of any Participant
affected thereby, may determine that some or all Participants holding outstanding Stock Options
shall receive, with respect to some or all of the shares of Common Stock subject to such Stock
Options, as of the effective date of any such Change in Control of the Company, cash in an amount
equal to the greater of the excess of (a) the highest sales price of the shares on the New York
Stock Exchange on the date immediately prior to the effective date of such Change in Control of the
Company or (b) the highest price per share actually paid in connection with any Change in Control
of the Company over the exercise price per share of such Stock Options.

8.3 Limitation on Change in Control Payments. Notwithstanding anything in subsection
8.1 or 8.2 to the contrary, if, with respect to a Participant, the acceleration of the vesting of
an Incentive Award as provided in subsection 8.1 or the payment of cash in exchange for all or part
of a Stock Option as provided in subsection 8.2 (which acceleration or payment could be deemed a
“payment” within the meaning of Section 280G(b)(2) of the Code), together with any other payments
that such Participant has the right to receive from the Company or any corporation that is a member
of an “affiliated group” (as defined in Section 1504(a) of the Code without regard to Section
1504(b) of the Code) of which the Company is a member, would constitute a “parachute payment” (as
defined in Section 280G(b)(2) of the Code), then the payments to such Participant pursuant to
subsection 8.1 or 8.2 shall be reduced to the largest amount as will result in no portion of such
payments being subject to the excise tax imposed by Section 4999 of the Code.

SECTION 9

General Provisions

9.1 No Rights to Awards. No Participant or other person shall have any claim to be
granted any Incentive Award under the Plan, and there is no obligation of uniformity of treatment
of Participants or holders or beneficiaries of Incentive Awards under the Plan. The terms and
conditions of Incentive Awards of the same type and the determination of the Committee to grant a
waiver or modification of any Incentive Award and the terms and conditions thereof need not be the
same with respect to each Participant.

9.2 Withholding. The Company or a Subsidiary shall be entitled to (a) withhold and
deduct from future wages of a Participant (or from other amounts that may be due and owing to a
Participant from the Company or a Subsidiary), or make other arrangements for the collection of,
all legally required amounts necessary to satisfy any and all federal, state, and local withholding
and employment-related tax requirements attributable to an Incentive Award, including, without
limitation, the grant, exercise, or vesting of, or payment of dividends with respect to, an
Incentive Award or a
disqualifying disposition of Common Stock received upon exercise of an incentive stock option; or
(b) require a Participant promptly to remit the amount of such withholding to the Company before
taking any action with respect to an Incentive Award. Unless the Committee determines otherwise,
withholding may be satisfied by withholding Common Stock to be received upon exercise or by
delivery to the Company of previously owned Common Stock. The Company may establish such rules and
procedures concerning timing of any withholding election as it deems appropriate to comply with
Rule 16b-3 under the Act.

 

10

 

9.3 Compliance With Laws; Listing and Registration of Shares. All Incentive Awards
granted under the Plan (and all issuances of Common Stock or other securities under the Plan) shall
be subject to all applicable laws, rules, and regulations, and to the requirement that if at any
time the Committee shall determine, in its discretion, that the listing, registration or
qualification of the shares covered thereby upon any securities exchange or under any state or
federal law, or the consent or approval of any governmental regulatory body, is necessary or
desirable as a condition of, or in connection with, the grant of such Incentive Award or the issue
or purchase of shares thereunder, such Incentive Award may not be exercised in whole or in part, or
the restrictions on such Incentive Award shall not lapse, unless and until such listing,
registration, qualification, consent, or approval shall have been effected or obtained free of any
conditions not acceptable to the Committee.

9.4 No Limit on Other Compensation Arrangements. Nothing contained in the Plan shall
prevent the Company or any Subsidiary from adopting or continuing in effect other or additional
compensation arrangements, including the grant of stock options and other stock-based awards, and
such arrangements may be either generally applicable or applicable only in specific cases.

9.5 No Right to Employment. The grant of an Incentive Award shall not be construed as
giving a Participant the right to be retained in the employ of the Company or any Subsidiary. The
Company or any Subsidiary may at any time dismiss a Participant from employment, free from any
liability or any claim under the Plan, unless otherwise expressly provided in the Plan or in any
written agreement with a Participant.

9.6 Governing Law. The validity, construction, and effect of the Plan and any rules
and regulations relating to the Plan shall be determined in accordance with the laws of the State
of Michigan and applicable federal law.

9.7 Severability. In the event any provision of the Plan shall be held illegal or
invalid for any reason, the illegality or invalidity shall not affect the remaining provisions of
the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had
not been included.

SECTION 10

Termination and Amendment

The Board may terminate the Plan at any time, or may from time to time amend the Plan as it
deems proper and in the best interests of the Company, provided that without stockholder approval
no such amendment may: (a) materially increase either the benefits to Participants under the Plan
or the number of shares that may be issued under
the Plan; (b) materially modify the eligibility requirements; or (c) impair any outstanding
Incentive Award without the consent of the Participant, except according to the terms of the Plan
or the Incentive Award, and provided further that the Plan may not be amended in any way that
causes the Plan to fail to comply with or be exempt from Section 409A of the Code, unless the Board
expressly determines to amend the Plan to be subject to Section 409A of the Code. No termination,
amendment, or modification of the Plan shall become effective with respect to any Incentive Award
previously granted under the Plan without the prior written consent of the Participant holding such
Incentive Award unless such amendment or modification operates solely to the benefit of the
Participant.

SECTION 11

Effective Date and Duration of the Plan

This Plan shall take effect April 27, 1993, subject to approval by the stockholders at the
1993 Annual Meeting of Stockholders or any adjournment thereof or at a Special Meeting of
Stockholders. Unless earlier terminated by the Board of Directors, the Plan shall terminate on
April 26, 2003. No Incentive Award shall be granted under the Plan after such date.

As amended October 9, 2008.

 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00154-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00154-of-00352.parquet"}]]